\
&
Contact us
This was 5 months ago
LocationHybrid - Brussels and online
ProgrammesThe forum will bring together key stakeholders from across Europe to take stock of the achievements of the Digital Education Action Plan throughout its 4 years of implementation and explore insightful take-aways from its review process.
The event will bridge stakeholder engagement with a forward-looking strategy for the future of digital education. It will provide an opportunity to learn, contribute and actively participate in shaping the 2030 Roadmap on the future of digital education and skills.
For more information and to register for the event, please visit the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.